The Innovative Medicines Initiative (IMI) is Europe's largest public-private initiative aiming to speed up the development of better and safer medicines for patients.

IMI supports collaborative research projects and builds networks of industrial and academic experts in order to boost pharmaceutical innovation in Europe.

IMI is a joint undertaking between the European Union and the pharmaceutical industry association EFPIA.

EU Logoefpia Logo


Sign up for the IMI 2 - Call 5 webinars

Webinars on all IMI2 - Call 5 topics plus IMI's rules and procedures will be held from 1 to 14 July inclusive.

The full schedule and registration information can be found on the webinar page.


  • A life-saving technology

    IMI project SUMMIT has developed an ultrasound device to identify patients at imminent risk of a heart attack or stroke

    ... more
  • Action on autism

    Watch a video on how EU-AIMS is developing tools to boost our understanding of autism, paving the way for new treatments

    ... more
  • Dealing with medicines benefits & risks

    The PROTECT project has developed tools and materials to help weigh up the benefits and risks of medicines

    ... more
  • Delivering results on severe asthma

    Learn about U-BIOPRED's findings & how they will make a difference for patients - Leuven, 24 June.

    ... more
  • Get on-course!

    With over 6 000 courses, on-course, run by the EMTRAIN project, is Europe's most comprehensive biomedical R&D postgrad course portal

    ... more
  • Innovation in action

    IMI's projects tackle some of the toughest challenges in medicine, including Alzheimer's disease, diabetes, & antibiotic development ... more

  • Patient power!

    EUPATI is developing educational resources that will empower patients to engage more effectively in the drug research and development process

    ... more
  • Towards better clinical trials

    The NEWMEDS project has developed DupCheck, a tool to spot duplicate enrolments in clinical trials

    ... more
  • Working in drug discovery?

    The European Lead Factory’s compound collection & screening facilities could help advance your research

    ... more
All projects


Pierre Meulien has been named as the new Executive Director of IMI.

He will take up his duties in mid-September.



  • 30/06/2015 : RT @RigaHealth15: “That’s what’s happening now: companies are pooling their knowledge” @EFPIA Richard Bergstrom speaks about @IMI_JU and co…
  • 30/06/2015 : IMI project news: join @SafeSciMET in Vienna end September for course on mutagenesis and #carcinogenesis. Info at
  • 30/06/2015 : RT @eupatients: Course Committee meeting in BRU. Planning the 2nd F2F meeting in BCN - It will be a thrill. #patientsinvolved

Follow us on Twitter